Researchers sought to determine whether educational intervention can decrease therapeutic inertia by reducing autonomic arousal response (pupil dilation), a proxy measurement of how physicians respond to uncertainty during clinical decisions.
Investigators evaluated the added value of incorporating data on the optic nerve region to current diagnostic criteria for patients with multiple sclerosis.
Study researchers found several clinical and imaging factors that predicted first-line treatment failure in patients with recently diagnosed relapsing remitting MS.
An electronic, unsupervised, patient-reported EDSS to assess disability in multiple sclerosis offers promise in clinical research and care for this population.
Study researchers investigated whether neurovascular contact with morphological changes influences the etiology of trigeminal neuralgia secondary to MS.
The approval was based on data from the phase 3b ENSEMBLE PLUS study that compared the frequency and severity of infusion-related reactions for a 2-hour Ocrevus infusion time to the previously approved 3.5-hour infusion time in patients with relapsing-remitting MS.